HomeInsightsPE

Emcure Pharmaceuticals Ltd PE Ratio

Emcure Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

4.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

PE

43.3

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Emcure Pharmaceuticals Ltd is 43.3 as of 23 Nov 09:59 AM .
  • The P/E Ratio of Emcure Pharmaceuticals Ltd changed from 0 on March 2019 to 0 on March 2024 . This represents a CAGR of 0.0% over 6 years.
  • The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 1313 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Emcure Pharmaceuticals Ltd

No data available

Company Fundamentals for Emcure Pharmaceuticals Ltd

No data available

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

Share Price

₹ 1313.6

29.40 (2.29%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241313.6
21 Nov 20241284.2
19 Nov 20241306.05
18 Nov 20241310.5
14 Nov 20241358.75
13 Nov 20241333.85
12 Nov 20241399.15
11 Nov 20241432.65
08 Nov 20241396.85
07 Nov 20241437.35

BlinkX Score for Emcure Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Emcure Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Emcure Pharmaceuticals Ltd4324,839
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Emcure Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Emcure Pharmaceuticals Ltd

No data available

* All values are in %

About Emcure Pharmaceuticals Ltd

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.

Emcure Pharmaceuticals Ltd News Hub

News

Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL

Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilit...

Read more

2024-08-13 00:00:00

News

Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities

Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigne...

Read more

2024-08-13 00:00:00

News

Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter

Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended J...

Read more

2024-08-14 00:00:00

News

Emcure Pharmaceuticals to declare Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 ...

Read more

2024-08-10 00:00:00

News

Emcure signs licensing agreement with Gilead Sciences

Emcure Pharmaceuticals announced the signing of a royalty-free voluntary licensing agreeme...

Read more

2024-10-03 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Emcure Pharmaceuticals Ltd

What is the current PE Ratio of Emcure Pharmaceuticals Ltd?

The Current PE Ratio of Emcure Pharmaceuticals Ltd is 43.27 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Emcure Pharmaceuticals Ltd last year?

The PE Ratio of Emcure Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 43.27, showing a year-on-year growth of -%.

What does the PE Ratio of Emcure Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Emcure Pharmaceuticals Ltd is 43.27. This ratio indicates that investors are willing to pay 43.27 times the earnings per share for each share of Emcure Pharmaceuticals Ltd.

What is the PE Ratio Growth of Emcure Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Emcure Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by 28.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*